We believe that in the future, PRDM5 methylation may also become part of cancer screening, and there is a blood-based screening for DNA methylation markers in colorectal cancer [19], we showed that epigenetic therapy of PRDM5 is achievable. Here, PRDM5 is linked to cancer.